Yes the resentment factor dwells with me too. Given the "self reported" conflict of interest process (that has no public airing) just sounds hokey to me. Time will tell.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come